Literature DB >> 12842611

Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination.

G Soboll1, D W Horohov, B M Aldridge, C W Olsen, M W McGregor, R J Drape, M D Macklin, W F Swain, D P Lunn.   

Abstract

We have previously demonstrated that hemagglutinin (HA) gene vaccination and influenza virus infection generate protective antibody responses in equids. However, these antibody responses differ substantially in that particle mediated DNA vaccination does not induce an immunoglobulin A (IgA) response. A study was performed to investigate the regional immunoregulatory mechanisms associated with these different immune responses. Ponies were either vaccinated with equine HA DNA vaccines at skin and mucosal sites, infected with influenza virus or left untreated and influenza-specific antibody responses and protection from challenge infection was studied. In a subset of ponies, lymphocytes from peripheral blood (PBLs), nasopharyngeal mucosal tissue, or lymph nodes (LNLs) were collected for measurement of influenza virus-specific lymphoproliferative responses, local antibody production and IL-2, IL-4 and IFN-gamma mRNA production by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). DNA vaccination and influenza virus infection induced humoral immunoglobulin Ga (IgGa) and immunoglobulin Gb (IgGb) production and lymphoproliferative responses that were positively correlated with IFN-gamma mRNA production. However, there were marked differences in immune response in that only influenza infection induced an IgA response, and the regional distribution of lymphoproliferation, IFN-gamma and antibody responses. Responses to DNA vaccination occurred in PBLs and in lymph nodes draining DNA vaccination sites, while influenza virus infection induced responses in PBLs and hilar LNLs. In summary, common features of immune responses to either influenza virus infection or DNA vaccination were virus-specific IgGa, IgGb and IFN-gamma responses, which are associated with protection from infection, even when the regional distribution of these immune responses varied depending on the site of immune encounter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842611     DOI: 10.1016/s0165-2427(03)00060-6

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  15 in total

1.  Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Authors:  Alida Ault; Alyse M Zajac; Wing-Pui Kong; J Patrick Gorres; Michael Royals; Chih-Jen Wei; Saran Bao; Zhi-yong Yang; Stephanie E Reedy; Tracy L Sturgill; Allen E Page; Jennifer Donofrio-Newman; Amanda A Adams; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers; Gary J Nabel; Srinivas S Rao
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

2.  Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Authors:  Yufeng Song; Xiang Wang; Hongbo Zhang; Xinying Tang; Min Li; Jufang Yao; Xia Jin; Hildegund C J Ertl; Dongming Zhou
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Equine Arteritis Virus Elicits a Mucosal Antibody Response in the Reproductive Tract of Persistently Infected Stallions.

Authors:  Mariano Carossino; Bettina Wagner; Alan T Loynachan; R Frank Cook; Igor F Canisso; Lakshman Chelvarajan; Casey L Edwards; Bora Nam; John F Timoney; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

4.  Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Zhen-Xing Tu; Yan-Fang Gong; Jing Jin; Hong-Yu Wu; Guo-Ming Xu
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

5.  Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Yan-Fang Gong; Hua Yang; Bo Sun; Jing Jin
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

6.  Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Authors:  R H Mealey; D M Stone; M T Hines; D C Alperin; M H Littke; S R Leib; S E Leach; S A Hines
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

7.  Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.

Authors:  T M Chambers; M Quinlivan; T Sturgill; A Cullinane; D W Horohov; D Zamarin; S Arkins; A García-Sastre; P Palese
Journal:  Equine Vet J       Date:  2009-01       Impact factor: 2.888

8.  Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.

Authors:  Gisela Soboll Hussey; Stephen B Hussey; Bettina Wagner; David W Horohov; Gerlinde R Van de Walle; Nikolaus Osterrieder; Lutz S Goehring; Sangeeta Rao; David P Lunn
Journal:  Vet Res       Date:  2011-02-07       Impact factor: 3.683

9.  In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence.

Authors:  Gudbjörg Olafsdóttir; Vilhjálmur Svansson; Sigurdur Ingvarsson; Eliane Marti; Sigurbjörg Torsteinsdóttir
Journal:  Acta Vet Scand       Date:  2008-11-04       Impact factor: 1.695

10.  The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.

Authors:  Melanie J Lewis; Bettina Wagner; Jenny M Woof
Journal:  Mol Immunol       Date:  2007-07-31       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.